Fort Pitt Capital Group, LLC Axonics, Inc. Transaction History
Fort Pitt Capital Group, LLC
- $3.53 Billion
- Q3 2024
A detailed history of Fort Pitt Capital Group, LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Fort Pitt Capital Group, LLC holds 5,000 shares of AXNX stock, worth $354,900. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,000
Previous 5,000
-0.0%
Holding current value
$354,900
Previous $336,000
3.57%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding AXNX
# of Institutions
18Shares Held
5.04MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY4.34MShares$308 Million0.01% of portfolio
-
Putnam Investments LLC Boston, MA239KShares$17 Million0.02% of portfolio
-
Segantii Capital Management LTD165KShares$11.7 Million1.41% of portfolio
-
Credit Suisse Ag Zurich, V899.6KShares$7.07 Million0.01% of portfolio
-
Eisler Capital (Uk) Ltd. London, X098.5KShares$6.99 Million0.03% of portfolio
About Axonics, Inc.
- Ticker AXNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 49,123,600
- Market Cap $3.49B
- Description
- Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...